Cargando…

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is a common malignancy worldwide with a poor prognosis. DNA methylation is an epigenetic modification that plays a critical role in the etiology and pathogenesis of HNSCC. The current study aimed to develop a predictive methylation signature based on bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Dayang, Wang, Mengmeng, Guo, Ying, Wu, Wei, Ji, Xiang, Dou, Xiaowen, Tang, Huamei, Zong, Zengyan, Zhang, Xiuming, Xiong, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419750/ https://www.ncbi.nlm.nih.gov/pubmed/34313009 http://dx.doi.org/10.1002/cam4.4142

Ejemplares similares

LINC00958 and HOXC13-AS as key candidate biomarkers in head and neck squamous cell carcinoma by integrated bioinformatics analysis
por: Xiong, Dan, et al.
Publicado: (2020)

Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients
por: Tang, Huamei, et al.
Publicado: (2020)

Analytical performance evaluation of five RT‐PCR kits for severe acute respiratory syndrome coronavirus 2
por: Wang, Mengmeng, et al.
Publicado: (2020)

Consistency evaluation of Liferiver, Yaneng, Darui, and the Cobas 4800 test for high‐risk human papillomavirus screening
por: Wang, Mengmeng, et al.
Publicado: (2020)

Comprehensive analysis of aberrantly expressed circRNAs, mRNAs and lncRNAs in patients with nasopharyngeal carcinoma
por: Guo, Feifan, et al.
Publicado: (2023)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas
por: Wong, Nathan, et al.
Publicado: (2016)

A TRP Family Based Signature for Prognosis Prediction in Head and Neck Squamous Cell Carcinoma
por: Pan, Fangfang, et al.
Publicado: (2022)

Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016)

FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma
por: Liang, Huazhen, et al.
Publicado: (2021)

Comparison of three automatic chemiluminescent immunoassays for monitoring dynamic profile of SARS‐CoV‐2 IgG and IgM
por: Dou, Xiaowen, et al.
Publicado: (2020)

KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma
por: Liu, Yi, et al.
Publicado: (2020)

FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis
por: Huang, Junjie, et al.
Publicado: (2021)

Prediction of radiotherapy response with a 5‐microRNA signature‐based nomogram in head and neck squamous cell carcinoma
por: Chen, Lin, et al.
Publicado: (2018)

Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset
por: Wu, Chaoying, et al.
Publicado: (2020)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2015)

A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma
por: Xu, Li, et al.
Publicado: (2021)

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
por: She, Yangyang, et al.
Publicado: (2020)

Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma
por: Lu, Yilong, et al.
Publicado: (2022)

Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas
por: Degli Esposti, Davide, et al.
Publicado: (2017)

Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma
por: Fan, Cui, et al.
Publicado: (2021)

The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma
por: Weed, Donald T., et al.
Publicado: (2023)

The expression and methylation of PITX genes is associated with the prognosis of head and neck squamous cell carcinoma
por: Zhao, Yaqiong, et al.
Publicado: (2022)

Aberrant Methylation Inactivates Transforming Growth Factor β Receptor I in Head and Neck Squamous Cell Carcinoma
por: Muñoz-Antonia, Teresita, et al.
Publicado: (2009)

Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review
por: Swartz, Justin E, et al.
Publicado: (2015)

Mitochondrial DNA copy number is associated with risk of head and neck squamous cell carcinoma in Chinese population
por: Wang, Lihua, et al.
Publicado: (2018)

Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations
por: Rangabashyam, Mahalakshmi S., et al.
Publicado: (2020)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma
por: Guo, Wenna, et al.
Publicado: (2017)

Development of a five-protein signature for predicting the prognosis of head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020)

Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma
por: Wan, Lingfei, et al.
Publicado: (2023)

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
por: Lin, Cheng, et al.
Publicado: (2023)

dbCNV: deleteriousness-based model to predict pathogenicity of copy number variations
por: Lv, Kangqi, et al.
Publicado: (2023)

The prognostic role of C‐reactive protein in patients with head and neck squamous cell carcinoma: A meta‐analysis
por: Chen, Yanglan, et al.
Publicado: (2020)

The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma
por: Ming, Ruijie, et al.
Publicado: (2021)

Performance evaluation of the XPEN60 CRP&SAA, a novel automated hematology analyzer, in detecting complete blood count, C‐reactive protein, and serum amyloid A
por: Zong, Zengyan, et al.
Publicado: (2020)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
por: Mei, Zi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_air5d7b2r2aafei7tkilgd7i7g